Trials / Withdrawn
WithdrawnNCT01293656
Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
Cross-sectional Study of Inflammatory Bowel Disease Severity and Treatment Patterns in Eastern Europe, Middle East, and North Africa. (P08166)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to assess the clinical course and treatment options for Crohn's Disease (CD) and ulcerative colitis (UC) in the populations of Eastern Europe, Middle East, and North Africa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention. | There is no study intervention. Participants will be treated locally per site standards. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-02-10
- Last updated
- 2015-06-02
Source: ClinicalTrials.gov record NCT01293656. Inclusion in this directory is not an endorsement.